Publicaciones en colaboración con investigadores/as de Harvard Medical School (66)

2024

  1. Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications

    Advanced Drug Delivery Reviews, Vol. 208

  2. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  3. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

  4. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.

    Psychiatry Research, Vol. 334

  5. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives

    Biomedicine and Pharmacotherapy, Vol. 179

  6. Nanoliposomes as nonviral vectors in cancer gene therapy

    MedComm, Vol. 5, Núm. 7

  7. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

  8. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  9. Regenerative cell therapy with 3D bioprinting

    Science (New York, N.Y.), Vol. 385, Núm. 6709, pp. 604-606

  10. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

  11. The Human Phenotype Ontology in 2024: phenotypes around the world

    Nucleic acids research, Vol. 52, Núm. D1, pp. D1333-D1346

  12. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711